KONGQI YU United States

Biopharmaceutical
Website:
www.merck.com
Company Size (Fulltime employees)
Please specify your partnering goal
NA
Headquartner in China
Biotech/Pharma Category
Merck
区域经理 

Xudong Yuan United States

ACON Pharmaceuticals Inc. (ACON Pharma) is a specialty pharmaceutical company and focuses on siRNA and mRNA nanoparticle delivery, 505(b)(2) NDA, and complex ANDA drug product development with its captive drug delivery system and technology platforms. Acon Pharma is a privately held corporation located in Princeton, New Jersey, USA. As a dynamic pharmaceutical company in a vibrant life science research region, Acon Pharma leverages the expertise and experience of highly skilled, multi-disciplinary workforce to accelerate the product development of complex drug delivery systems. The Company’s key managers were primarily educated in US with advanced degrees and trained in the pharmaceutical industry for many years, and have possessed deep professional knowledge, technical know-how, and extensive experiences in pharmaceutical product development.

We are currently raising 5 million dollar fund to support IND-enabling studies for our patented liposomal siRNA for treatment of pulmonary fibrosis and long-acting microsphere for treatment of schizophrenia. We are also developing delayed release nanoemulsion for osteoporosis, and sustained release gel for fungal infection.
Company Size (Fulltime employees)
Year of foundation
2020
Please specify your partnering goal
Looking for investors and strategic partners
Headquartner in China
Assets Information 1
AP1302|siRNA Liposome Inhalation|pulmonary fibrosis|China, US
Assets Information 2
AP2602|Long-acting Microsphere Injection|schizophrenia, bipolar disease|China, US
Assets Information 3
AP6111|Self-emulsifying Nanoemulsion|osteoporosis|China, US
Biotech/Pharma Asset Stage
Acon Pharmaceuticals Inc
CEO 
Functionality

Terry YUAN

港资上市公司
Partnering Objectives
Headquartner in China
叶氏化工
经理 

Derek Yuan United States

We manage about $1.4B and we are focused on life science industry

Lyfe capital
Senior Associate  

Mr. Yingming Yue United States

Huahai Pharmaceutical
Company Size (Fulltime employees)
Partnering Objectives
Please specify your partnering goal
Business Development
Headquartner in China
Prinston Pharma
VP, operations 
Functionality

shen yuli China

we are a company focusing on the research and development of new drug
Website:
www.aitectt.cn
Partnering Objectives
Headquartner in China
Shanghai徽锐生物科技有限公司
GM